Breakthrough Immunosuppressive Therapies

WCMC has a long tradition of excellence in immunology, which has helped us achieve a high level of graft acceptance rates.

Our physicians and researchers are considered leaders in immunosuppression -- or the prevention and treatment of organ rejection. They have helped develop and/or refine many important anti-rejection medications, including OKT3, which was a mainstay immunosuppression drug for more than a decade.

Thankfully, the science of immunosuppression has become so accurate that organ rejection is now a relatively uncommon occurrence in patients who take their medications as prescribed. With that challenge met, our physicians and researchers are focusing on the next challenge: preventing and treating other common problems that develop in transplant patients, such as high blood pressure, scarring that develops in transplanted organs, and viral infections.